Argo CK, Caldwell SH

Idioma: Ingles.
Referencias bibliográficas: 6
Paginas: 777-779
Archivo PDF: 59.99 Kb.

FRAGMENTO

Sin resumen.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published be tween 1965 and 2013. Lancet 2015. pii: S0140-6736(15) 61412-X. Doi: 10.1016/S0140-6736(15)61412-X [Epub ahead of print].

2. Qin G1, Shao JG, Wang B, Shen Y, Zheng J, Liu XJ, Zhang YY, et al. Artificial liver support system improves shortand long-term outcomes of patients with HBV-associated acute-on-chronic liver failure: a single-center experience. Medicine (Baltimore) 2014; 93: e338.

3. Kim CH, Um SH, Seo YS, Jung JY, Kim JD, Yim HJ, Keum B, et al. Prognosis of hepatitis B-related liver cirrhosis in the era of oral nucleos(t)ide analog antiviral agents. J Gastroenterol Hepatol 2012; 27: 1589-95.

4. Merion RM, Schaubel DE, Dykstra DM, Freeman RB, Port FK, Wolfe RA. The survival benefit of liver transplantation. Am J Transplant 2005; 5: 307-13.

5. Schaubel DE, Sima CS, Goodrich NP, Feng S, Merion RM. The survival benefit of deceased donor liver transplantation as a function of candidate disease severity and donor quality. Am J Transplant 2008; 8: 419-25.

6. Berg CL, Merion RM, Shearon TH, Olthoff KM, Brown RS Jr, Baker TB, Everson GT, et al. Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era. Hepatology 2011; 54: 1313-21.